Stevens CW - Search Results

1

Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.

Davis RL, Das S, Buck DJ, Stevens CW. Davis RL, et al. Among authors: stevens cw. Neurochem Int. 2013 Mar;62(4):478-85. doi: 10.1016/j.neuint.2013.01.013. Epub 2013 Jan 31. Neurochem Int. 2013. PMID: 23376103 Free PMC article.

2

Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells.

Davis RL, Buck DJ, Saffarian N, Mohan S, DeSilva U, Fernando SC, Stevens CW. Davis RL, et al. Among authors: stevens cw. J Neuroimmune Pharmacol. 2008 Sep;3(3):150-3. doi: 10.1007/s11481-008-9102-x. Epub 2008 Feb 16. J Neuroimmune Pharmacol. 2008. PMID: 18278557 Free PMC article.

3

The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Davis RL, Das S, Thomas Curtis J, Stevens CW. Davis RL, et al. Among authors: stevens cw. Eur J Pharmacol. 2015 Sep 5;762:193-201. doi: 10.1016/j.ejphar.2015.05.040. Epub 2015 May 22. Eur J Pharmacol. 2015. PMID: 26007645 Free PMC article.

4

The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice.

Davis RL, Stevens CW, Thomas Curtis J. Davis RL, et al. Among authors: stevens cw. Physiol Behav. 2017 May 1;173:52-60. doi: 10.1016/j.physbeh.2017.01.037. Epub 2017 Jan 24. Physiol Behav. 2017. PMID: 28130086

5

The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Davis RL, Buck DJ, Saffarian N, Stevens CW. Davis RL, et al. Among authors: stevens cw. J Neuroimmunol. 2007 May;186(1-2):141-9. doi: 10.1016/j.jneuroim.2007.03.021. Epub 2007 May 1. J Neuroimmunol. 2007. PMID: 17475341 Free PMC article.

6

Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Mohan S, Davis RL, DeSilva U, Stevens CW. Mohan S, et al. Among authors: stevens cw. J Neuroimmunol. 2010 Oct 8;227(1-2):26-34. doi: 10.1016/j.jneuroim.2010.06.007. Epub 2010 Jul 7. J Neuroimmunol. 2010. PMID: 20615556 Free PMC article.

7

Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.

Stevens CW, Aravind S, Das S, Davis RL. Stevens CW, et al. Br J Pharmacol. 2013 Mar;168(6):1421-9. doi: 10.1111/bph.12028. Br J Pharmacol. 2013. PMID: 23083095 Free PMC article.

8

Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals.

Stevens CW, Brasel CM, Mohan S. Stevens CW, et al. Neurosci Lett. 2007 Jun 4;419(3):189-94. doi: 10.1016/j.neulet.2007.04.014. Epub 2007 Apr 11. Neurosci Lett. 2007. PMID: 17452077 Free PMC article.

9

Nociceptin produces antinociception after spinal administration in amphibians.

Stevens CW, Martin KK, Stahlheber BW. Stevens CW, et al. Pharmacol Biochem Behav. 2009 Jan;91(3):436-40. doi: 10.1016/j.pbb.2008.08.022. Epub 2008 Sep 5. Pharmacol Biochem Behav. 2009. PMID: 18804120 Free PMC article.

10

A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.

Brasel CM, Sawyer GW, Stevens CW. Brasel CM, et al. Among authors: stevens cw. Eur J Pharmacol. 2008 Dec 3;599(1-3):36-43. doi: 10.1016/j.ejphar.2008.09.043. Epub 2008 Oct 9. Eur J Pharmacol. 2008. PMID: 18930720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters